Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bacillus viable particles for prevention of antibiotic-associated diarrhea in hospitalized children
ChiCTR-IPR-16009033Phase 4Not yet recruiting
- Sponsor
- Shenzhen Children's Hospital
- Start
- Sep 2016
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of live Bacillus licheniformis granules in antibiotic-associated diarrhea (AAD) (2 arms), sponsored by Shenzhen Children's Hospital. Primary endpoints: Incidence of diarrhea, Time to occurrence of diarrhea and 1 more. Planned start Sep 2016; status: not yet recruiting.
02
Drugs
live Bacillus licheniformis granules
03
Conditions
antibiotic-associated diarrhea (AAD)
Beyond the preview
Go deeper on ChiCTR-IPR-16009033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16009033.